What changes
- OEM field service ends.
- OEM parts availability becomes limited or ends.
- Future software and operating system compatibility may become more constrained.
- The laboratory needs a defined alternative for service, repair and critical parts.
iCAP Q service continuity
Your iCAP Q still has work to do.
Thermo Fisher has announced End of Guaranteed Support and Retirement dates for the iCAP Q. For laboratories that still rely on these systems, the practical question is whether the instrument needs to be replaced, or whether it simply needs a different service strategy.
September 30, 2027
End of Guaranteed Support begins
OEM parts and billable repair may become availability dependent during the EOGS period.
September 30, 2028
Thermo Fisher service retirement
OEM service and support for the iCAP Q are scheduled to end.
After retirement
Independent support remains an option
Ionflight supports iCAP Q systems through field service, repair, parts and lifecycle planning.
What the OEM deadline means
Service retirement changes the support model. It does not automatically change the instrument.
An iCAP Q that is meeting QC, method and throughput requirements on September 29, 2028 does not become analytically obsolete on September 30. What changes is the availability of OEM support.
What does not automatically change
- Performance of a properly operating instrument.
- Established methods already running successfully.
- Operator familiarity with the platform.
- Existing sample preparation, autosampler and data workflows.
- Value to daily production.
The relevant question is whether the Q still does the work required of it and whether the remaining service risks can be managed responsibly.
A practical decision framework
Continue operating when the case is sound. Replace when the case to replace is stronger.
The decision should be based on the instrument, the laboratory and the consequences of downtime.
| Consideration | Continued operation is reasonable when… | Replacement should be planned when… |
|---|---|---|
| Analytical performance | The Q continues to meet the laboratory’s required methods, QC criteria and reporting limits. | Required methods or analytical capabilities have outgrown the platform. |
| Throughput & reliability | Daily capacity is adequate and failures are infrequent, understood and serviceable. | Downtime, repeat failures or capacity limitations are affecting turnaround time or commitments to customers. |
| Supportability | Critical parts have a viable supply, repair or spare path. | A support limiting component has no practical replacement or repair route. |
| Software & IT | The existing control PC, Qtegra environment and network requirements remain manageable. | Operating system, cybersecurity, integration or data management requirements can no longer be met acceptably. |
| Business impact | Replacing now would add disruption and capital cost without a corresponding operational benefit. | A planned migration now is less risky or less costly than continuing to operate the existing system. |
The right outcome may be continue operating, continue with specific risk controls, or plan replacement.
iCAP Q Lifecycle Extension Guide
Work through the questions before you decide.
Use the downloadable guide to organize what EOGS and Retirement mean, parts and service considerations, and the questions to think through before extending or replacing.
Review your iCAP Q options
Know the service path before a part fails.
For a laboratory considering operation beyond OEM retirement, the issue is whether there is a credible service and parts path for that specific system. A Lifecycle Review makes the constraints visible before an outage.
1
Current condition
Recent service history, recurring faults and the instrument’s operational role.
2
Critical parts
Availability, repair routes and components with long lead times.
3
Spares and maintenance
Recommendations based on lead time, downtime risk and preventive maintenance priorities.
4
Known limits
PC, Qtegra and IT constraints, plus conditions that would trigger replacement planning.
There will be limits. Not every component will remain available or repairable indefinitely. A responsible plan identifies those limits in advance.
How Ionflight supports the iCAP Q
One service partner across the Thermo ICP-MS lifecycle.
Ionflight has serviced Thermo Scientific ICP-MS systems since 2002. Support is built around the failure modes and constraints of the instrument you have.
Field service and troubleshooting
Diagnosis, repair and return to performance work in the laboratory.
Preventive maintenance
Planned maintenance focused on reliability and developing issues.
Bench and board level repair
Component level diagnosis and repair where technically appropriate.
Parts and critical spares planning
Available, repairable and long lead components assessed against downtime risk.
PC and software continuity
Planning around the control computer, Qtegra, operating system, peripherals and site IT.
Service documentation and contracts
Documented work and support options aligned with maintenance and quality requirements.
For high throughput testing laboratories
An instrument migration is an operations project, not just a purchase.
When an analyzer is replaced, the work can extend beyond installation and qualification, particularly in commercial environmental and drinking water laboratories.
Operator training and competency documentation
SOP and work instruction updates
Method verification or validation activities
QC trending and baseline changes
LIMS, network and data transfer changes
Accreditation and quality system documentation
Production scheduling during transition
Those costs may be justified when a new platform provides a needed benefit. They matter when the existing Q is performing satisfactorily and can be supported.
What an iCAP Q Lifecycle Review covers
Establish the support risk before you decide on replacement.
Ionflight can review the instrument’s condition, service history, software environment, major assemblies and operational role to identify what is likely to constrain continued use.
The result should support one of three conclusions: continue operating, continue with specific risk controls, or plan replacement.
Typical review areas
- Instrument condition and recurring faults
- Critical parts and repair routes
- Spares based on lead time and downtime risk
- Control PC, Qtegra and IT constraints
- Preventive maintenance priorities
- Conditions that trigger replacement planning
Technical context
The MSX is newer. That alone does not make every Q replacement necessary.
The iCAP MSX adds meaningful improvements in areas such as automation, matrix handling, electronics and workflow. Thermo Fisher’s published specifications also show substantial continuity in the core single quadrupole analytical platform. Service retirement and analytical obsolescence are separate questions.
View the full iCAP Q vs. iCAP MSX comparison
| Consideration | iCAP Q | iCAP MSX | What it means |
|---|---|---|---|
| Core platform | Single-quadrupole ICP-MS | Single-quadrupole ICP-MS | The replacement decision is not a move to a fundamentally different analyzer class. |
| Sensitivity | Established iCAP Q performance | Higher sensitivity | More signal can provide analytical headroom, but sensitivity alone does not determine practical detection limits. |
| Detection limits | Meets established Q specifications | Similar for many major elements | If current methods are already comfortably within required limits, the analytical benefit of replacement may be modest. |
| Productivity & automation | Capabilities available through configuration and options | More capabilities standardized and integrated | The MSX may simplify routine workflows, but the value depends on what your lab actually needs. |
| High-matrix handling | Supported through appropriate interface/configuration strategies | Greater integration around high-matrix workflows | This can be a meaningful advantage for labs routinely handling demanding high-TDS samples. |
| Maintenance & monitoring | Established diagnostics and maintenance approach | Newer monitoring and maintenance features | Operational convenience may improve, but the value should be weighed against current Q reliability and serviceability. |
| Lifecycle position | EOGS begins Sept. 30, 2027; Retirement Sept. 30, 2028 | Current platform | Long-term supportability is the clearest structural reason to plan ahead. |
| Capital investment | Existing asset | Approx. $200K–$250K replacement | Replacement should create enough analytical, operational or risk-reduction value to justify the investment. |
Get a clear plan for your iCAP Q.
Review condition, parts, repair paths, maintenance, software constraints and replacement timing in one conversation.
iCAP Q Lifecycle Review
Discuss your instrument before the service model changes.
If your laboratory expects to operate an iCAP Q beyond OEM retirement, Ionflight can review the practical service and parts risks with you.
Instrument currently down? Call 617-337-2201.
FAQ
Common questions
Does OEM retirement mean we need to replace the instrument?
No automatic conclusion follows from the service date alone. Assess whether the Q still meets laboratory requirements and whether foreseeable support risks can be managed.
Is Ionflight claiming the Q and MSX are the same instrument?
No. The MSX has newer capabilities. The decision depends on whether those capabilities matter to your methods and workflow, as well as the Q’s supportability.
How long can an iCAP Q realistically remain in service?
That depends on its condition, parts and repair paths, software environment, workload and tolerance for downtime. A Lifecycle Review identifies the limits for your system.